CAR T Cell Therapy Reaches Beyond Cancer – Penn Bioengineering Blog
Penn Medicine researchers report promising early results for CAR T therapy in lupus patients, highlighting its potential beyond blood cancers. CAR T cells, engineered from a patient's own cells, target specific cell types, offering a personalized treatment approach. This development underscores the broader applicability of CAR T therapies in autoimmune diseases like lupus, driven by B cells.
Reference News
Penn Medicine researchers report promising early results for CAR T therapy in lupus patients, highlighting its potential beyond blood cancers. CAR T cells, engineered from a patient's own cells, target specific cell types, offering a personalized treatment approach. This development underscores the broader applicability of CAR T therapies in autoimmune diseases like lupus, driven by B cells.